| 11168090 |
Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors |
Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, David A. Moreno +2 more |
2021-11-09 |
| 11098064 |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile |
Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more |
2021-08-24 |
| 10966985 |
Macrocyclic compounds as ROS1 kinase inhibitors |
Steven W. Andrews, James F. Blake, Julia Haas |
2021-04-06 |
| 10953005 |
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more |
2021-03-23 |
| 10907215 |
Point mutations in TRK inhibitor-resistant cancer and methods relating to the same |
Nisha Nanda, Joshua H. Bilenker, James F. Blake, Barbara J. Brandhuber, Steven W. Andrews |
2021-02-02 |
| 10889589 |
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain |
Shelley Allen, Steven W. Andrews, James F. Blake, Barbara J. Brandhuber, Julia Haas +4 more |
2021-01-12 |
| 10881652 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more |
2021-01-05 |